| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $41.3M | -6.7% |
| Cost of Revenue | $4.7M | -7.0% |
| Gross Profit | $36.5M | -6.7% |
| R&D Expense | $23.8M | +22.0% |
| SG&A Expense | $30.1M | +16.4% |
| Operating Income | -$48.3M | -76.5% |
| Net Income | -$37.9M | -60.9% |
| EPS (Basic) | -$0.37 | -60.9% |
| EPS (Diluted) | -$0.37 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $46.5M | +320.3% |
| Short-term Investments | $121.8M | -43.7% |
| Accounts Receivable | $5.8M | -50.4% |
| Inventory | $12.2M | +42.5% |
| Current Assets | $190.2M | -24.6% |
| Total Assets | $268.3M | -6.4% |
| Current Liabilities | $17.9M | +15.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.7M | -46.7% |
| Capital Expenditures | $3.7M | -80.0% |
| Investing Cash Flow | $55.0M | +321.5% |
| Financing Cash Flow | $2.1M | -25.8% |
| Free Cash Flow | -$25.4M | +23.7% |
| -60.9% |
| Total Liabilities |
| $36.1M |
| +10.5% |
| Stockholders' Equity | $232.2M | -8.6% |